サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1701683

哺乳類細胞バンキングの世界市場：業界分析、規模、シェア、成長、動向、予測（2025年～2032年）

Mammalian Cell Banking Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032

出版日
ページ情報
英文 251 Pages
納期
2～5営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.87円
哺乳類細胞バンキングの世界市場：業界分析、規模、シェア、成長、動向、予測（2025年～2032年）
出版日: 2025年04月09日
発行: Persistence Market Research
ページ情報: 英文 251 Pages
納期: 2～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の哺乳類細胞バンキングの市場規模は、2025年に5億6,700万米ドルになるとみられ、2025年～2032年の予測期間に14.0%のCAGRで拡大し、2032年には14億1,880万米ドルに達すると予測されています。

哺乳類細胞バンキング市場には、生物製剤製造、遺伝子治療、ワクチン製造に不可欠な哺乳類細胞由来の細胞株の開発、保管、メンテナンスが含まれます。細胞バンクは、バイオ医薬品製造における一貫性、品質、安全性を保証します。モノクローナル抗体、細胞・遺伝子治療、個別化医療への需要が世界的に高まる中、哺乳類細胞バンキングは信頼性と拡張性の高い生産プロセスを確保する上で重要な要素となっています。

哺乳類細胞バンキング市場は、いくつかの有力な要因によって力強い成長を遂げています。主要な促進要因は、生物製剤やバイオシミラーに対する需要の高まりであり、これらの製剤は生産に安定したよく特性化された哺乳類細胞株を必要とします。個別化医療や細胞・遺伝子治療への注目の高まりは、安全で高品質な細胞バンクシステムの必要性をさらに加速させています。CRISPRベースのエンジニアリングやハイスループットスクリーニングなど、細胞株開拓における技術の進歩も市場拡大に寄与しています。さらに、細胞バンキングにおける適正製造基準（GMP）の使用に対する規制当局の支援は、製品の品質とコンプライアンスを強化し、市場を前進させています。

哺乳類細胞バンキング市場は、その成長可能性にもかかわらず、いくつかの課題に直面しています。特に中小企業にとっては、GMP準拠施設の設立に伴う高額な初期投資と運営コストが大きな障壁となる可能性があります。さらに、新しい細胞株に対する複雑で時間のかかる規制当局の承認プロセスは、製品開発を遅らせる可能性があります。また、汚染、遺伝子ドリフト、長期保存におけるばらつきに関連するリスクもあり、そのため厳格な品質管理とモニタリングシステムが必要となり、コストと複雑さに拍車をかけています。

哺乳類細胞バンキング市場は、拡大・革新の機会を数多く提供しています。特に腫瘍学や希少疾患において、生物製剤や先進治療を含む臨床試験が増加しているため、多様で信頼性の高い細胞バンクに対する需要が高まっています。アジア太平洋とラテンアメリカの新興市場は、バイオ医薬品製造能力を急速に拡大しており、新たなビジネス見通しを提供しています。さらに、バイオ製薬企業とCROが共同でセルバンキングサービスを外注するケースも増えており、拡張性と効率性を実現しています。AIを活用した品質管理やデジタルバイオバンキングプラットフォームなど、自動化やデジタル技術への投資も、標準化やオペレーションの卓越性を高める扉を開きます。

当レポートでは、世界の哺乳類細胞バンキング市場について調査し、細胞別、技術別、用途別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場概要

第3章 主要な市場動向

第4章 重要成功要因

  • パイプライン評価
  • バリューチェーン分析
  • 主要メーカー別主要プロモーション戦略
  • 規制状況
  • PESTLE分析
  • ポーター分析

第5章 市場背景

第6章 COVID-19危機- 影響評価

  • COVID-19と影響分析
  • 2022年の市場シナリオ

第7章 世界の哺乳類細胞バンキング市場の見通し、2019年～2032年

  • 過去の市場金額分析、2019年～2024年
  • 現在および将来の市場金額予測、2025年～2032年

第8章 世界の哺乳類細胞バンキング市場の見通し、2019年～2032年、細胞別

  • イントロダクション/主な調査結果
  • 過去の市場規模分析、細胞別、2019年～2024年
  • 現在および将来の市場規模分析および予測、細胞別、2025年～2032年
  • 細胞別の市場の魅力分析

第9章 世界の哺乳類細胞バンキング市場の見通し、2019-2032年、技術別

  • イントロダクション/主な調査結果
  • 過去の市場規模分析、技術別、2019年～2024年
  • 現在および将来の市場規模分析および予測、技術別、2025年～2032年
  • 技術別の市場の魅力分析

第10章 世界の哺乳類細胞バンキング市場の見通し、2019年～203、用途別

  • イントロダクション/主な調査結果
  • 過去の市場規模分析、用途別、2019年～2024年
  • 現在および将来の市場規模分析および予測、用途別、2025年～2032年
  • 用途別の市場の魅力分析

第11章 世界の哺乳類細胞バンキング市場の見通し、2019年～2032年、エンドユーザー別

  • イントロダクション/主な調査結果
  • 過去の市場規模分析、エンドユーザー別、2019年～2024年
  • 現在および将来の市場規模分析および予測、エンドユーザー別、2025年～2032年
    • 学術研究機関
    • バイオ医薬品企業
    • CRO
  • エンドユーザー別の市場の魅力分析

第12章 世界の哺乳類細胞バンキング市場の見通し、2019年～2032年、地域別

  • イントロダクション
  • 過去の市場規模分析、地域別、2019年～2024年
  • 現在および将来の市場規模分析および予測、地域別、2025年～2032年
    • 北米
    • ラテンアメリカ
    • 欧州
    • 東アジア
    • 南アジア
    • オセアニア
    • 中東・アフリカ
  • 地域別の市場の魅力分析

第13章 北米の哺乳類細胞バンキング市場の見通し、2019年～2032年

第14章 ラテンアメリカの哺乳類細胞バンキング市場の見通し、2019年～2032年

第15章 欧州の哺乳類細胞バンキング市場の見通し、2019年～2032年

第16章 南アジアの哺乳類細胞バンキング市場の見通し、2019年～2032年

第17章 東アジアの哺乳類細胞バンキング市場の見通し、2019年～2032年

第18章 オセアニアの哺乳類細胞バンキング市場

第19章 中東・アフリカの哺乳類細胞バンキング市場の見通し、2019年～2032年

第20章 市場構造分析

第21章 競合分析

  • 競合ダッシュボード
  • 競合ベンチマーク
  • 競合の詳細
    • Eurofins DiscoverX Corporation
    • Merck KGaA
    • Sartorius Stedim BioOutsource Limited.
    • Charles River Laboratories
    • Altogen Labs
    • Abzena Ltd
    • Northway Biotechpharma
    • Lonza Group Ltd
    • VIRUSURE
    • Selexis SA
    • Sigma-Aldrich
    • Takara Bio Inc

第22章 前提と使用される頭字語

第23章 調査手法

目次
Product Code: PMRREP31663

Persistence Market Research has recently released a comprehensive report on the global Mammalian Cell Banking Market, providing an in-depth analysis of key market dynamics, including driving forces, emerging trends, opportunities, and challenges. This report offers a detailed understanding of the market landscape, helping stakeholders make well-informed decisions.

Key Insights:

  • Mammalian Cell Banking Market Size (2025E): USD 567.0 Mn
  • Projected Market Value (2032F): USD 1,418.8 Mn
  • Global Market Growth Rate (CAGR 2025 to 2032): 14.0%

Mammalian Cell Banking Market - Report Scope:

The mammalian cell banking market includes the development, storage, and maintenance of cell lines derived from mammalian cells, which are essential for biologics manufacturing, gene therapy, and vaccine production. Cell banks ensure consistency, quality, and safety in the production of biopharmaceuticals. As demand for monoclonal antibodies, cell and gene therapies, and personalized medicine increases globally, mammalian cell banking has become a critical component in ensuring reliable and scalable production processes.

Market Growth Drivers:

The mammalian cell banking market is experiencing strong growth driven by several influential factors. A major driver is the rising demand for biologics and biosimilars, which require stable and well-characterized mammalian cell lines for production. The increasing focus on personalized medicine and cell & gene therapies has further accelerated the need for secure and high-quality cell banking systems. Technological advancements in cell line development, such as CRISPR-based engineering and high-throughput screening, are also contributing to market expansion. In addition, regulatory support for the use of Good Manufacturing Practices (GMP) in cell banking enhances product quality and compliance, propelling the market forward.

Market Restraints:

Despite its growth potential, the mammalian cell banking market faces some challenges. High initial investment and operational costs associated with establishing GMP-compliant facilities can be a significant barrier, especially for small and mid-sized enterprises. Moreover, the complex and time-consuming regulatory approval processes for new cell lines can delay product development. There are also risks associated with contamination, genetic drift, or variability in long-term storage, which necessitate stringent quality control and monitoring systems, adding to the cost and complexity.

Market Opportunities:

The mammalian cell banking market presents numerous opportunities for expansion and innovation. The increasing number of clinical trials involving biologics and advanced therapies, particularly in oncology and rare diseases, is creating demand for diverse and reliable cell banks. Emerging markets in Asia-Pacific and Latin America are rapidly expanding their biopharmaceutical manufacturing capabilities, offering new business prospects. In addition, collaborations between biopharma companies and CROs to outsource cell banking services are on the rise, enabling scalability and efficiency. Investment in automation and digital technologies, such as AI-driven quality control and digital biobanking platforms, also opens doors for greater standardization and operational excellence.

Key Questions Answered in the Report:

  • What are the primary factors driving the global mammalian cell banking market's growth?
  • Which cell types and applications are dominating the mammalian cell banking landscape?
  • How are biopharmaceutical trends shaping future cell banking strategies?
  • Who are the key players in the mammalian cell banking market, and what strategies are they adopting?
  • What are the growth opportunities in emerging regions?

Competitive Intelligence and Business Strategy:

Leading companies in the mammalian cell banking market, such as Eurofins DiscoverX Corporation, Merck KGaA, Sartorius Stedim BioOutsource Limited, Charles River Laboratories, and Lonza Group Ltd, are focusing on expanding their GMP-compliant manufacturing facilities and enhancing service portfolios to meet global biopharma demand. Strategic partnerships with biotech firms and academic institutes, along with R&D investments in innovative cell line technologies, are key to maintaining a competitive edge. Companies are also emphasizing quality assurance, contamination prevention, and regulatory alignment to boost client confidence and streamline product development pipelines.

Companies Covered in This Report:

  • Eurofins DiscoverX Corporation
  • Merck KGaA
  • Sartorius Stedim BioOutsource Limited
  • Charles River Laboratories
  • Altogen Labs
  • Abzena Ltd
  • Northway Biotechpharma
  • Lonza Group Ltd
  • VIRUSURE
  • Selexis SA
  • Takara Bio Inc

Key Segments Covered in Manufacturing of Industry Research:

Cell Type:

  • CHO
  • BHK
  • NS0
  • YB2/0 & P2/0
  • HEK293 & Derivatives
  • HELA

Technology:

  • TEP
  • IEP
  • SEP

Application:

  • MCB (Master Cell Bank)
  • WCB (Working Cell Bank)
  • EoP (End of Production)
  • R&D CB (Research & Development Cell Bank)

End User:

  • Academic & Research Institutes
  • Biopharmaceutical Companies
  • CROs (Contract Research Organizations)

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • The Middle East & Africa (MEA)

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply-Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusions and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Development/Innovation Trends

4. Key Success Factors

  • 4.1. Pipeline Assessment
  • 4.2. Value chain Analysis
  • 4.3. Key Promotional Strategies, By Key Manufacturers
  • 4.4. Regulatory Landscape
  • 4.5. PESTLE Analysis
  • 4.6. Porter's Analysis

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Growth Outlook
    • 5.1.2. Global Healthcare Expenditure
    • 5.1.3. Global Cell Banking Outsourcing Market Outlook
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Key Player's Historic Growth
    • 5.2.2. Market Consolidation Activities
    • 5.2.3. Increasing Geriatric Population
    • 5.2.4. Rising Cases of Cancer
    • 5.2.5. Growing Preference of Mammalian Cell Banking
    • 5.2.6. Increased R&D investments by Government
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis - Impact Assessment

  • 6.1. COVID-19 and Impact Analysis
    • 6.1.1. By Cell
    • 6.1.2. By Technology
    • 6.1.3. By Application
    • 6.1.4. By End User
    • 6.1.5. By Region
  • 6.2. 2022 Market Scenario

7. Global Mammalian Cell Banking Market Outlook, 2019-2032

  • 7.1. Historical Market Value (US$ Mn) Analysis, 2019-2024
  • 7.2. Current and Future Market Value (US$ Mn) Projections, 2025-2032
    • 7.2.1. Y-o-Y Growth Trend Analysis
    • 7.2.2. Absolute $ Opportunity Analysis

8. Global Mammalian Cell Banking Market Outlook, 2019-2032 , By Cell

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Mn) Analysis By Cell, 2019-2024
  • 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Cell, 2025-2032
  • 8.4. Market Attractiveness Analysis By Cell

9. Global Mammalian Cell Banking Market Outlook, 2019-2032 , By Technology

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Mn) By Technology, 2019-2024
  • 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Technology, 2025-2032
  • 9.4. Market Attractiveness Analysis By Technology

10. Global Mammalian Cell Banking Market Outlook, 2019-2032 , By Application

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Mn) Analysis By Application, 2019-2024
  • 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2025-2032
  • 10.4. Market Attractiveness Analysis By Application

11. Global Mammalian Cell Banking Market Outlook, 2019-2032 , By End User

  • 11.1. Introduction / Key Findings
  • 11.2. Historical Market Size (US$ Mn) By End User, 2019-2024
  • 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2025-2032
    • 11.3.1. Academic & Research Institute
    • 11.3.2. Biopharmaceutical Companies
    • 11.3.3. CROs
  • 11.4. Market Attractiveness Analysis By End User

12. Global Mammalian Cell Banking Market Outlook, 2019-2032 , By Region

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Mn) Analysis by Region, 2019-2024
  • 12.3. Current Market Size (US$ Mn) Analysis and Forecast by Region, 2025-2032
    • 12.3.1. North America
    • 12.3.2. Latin America
    • 12.3.3. Europe
    • 12.3.4. East Asia
    • 12.3.5. South Asia
    • 12.3.6. Oceania
    • 12.3.7. Middle East and Africa (MEA)
  • 12.4. Market Attractiveness Analysis By Region

13. North America Mammalian Cell Banking Market Outlook, 2019-2032

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2024
  • 13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2025-2032
    • 13.3.1. By Country
      • 13.3.1.1. U.S.
      • 13.3.1.2. Canada
  • 13.4. Market Attractiveness Analysis
  • 13.5. Market Trends
  • 13.6. Key Market Participants - Intensity Mapping
  • 13.7. Drivers and Restraints - Impact Analysis
  • 13.8. Country Level Analysis & Forecast
    • 13.8.1. U.S. Mammalian Cell Banking Market Analysis
      • 13.8.1.1. Introduction
      • 13.8.1.2. Market Analysis and Forecast by Market Taxonomy
    • 13.8.2. Canada Mammalian Cell Banking Market Analysis
      • 13.8.2.1. Introduction
      • 13.8.2.2. Market Analysis and Forecast by Market Taxonomy

14. Latin America Mammalian Cell Banking Market Outlook, 2019-2032

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2024
  • 14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2025-2032
    • 14.3.1. By Country
      • 14.3.1.1. Mexico
      • 14.3.1.2. Brazil
      • 14.3.1.3. Argentina
      • 14.3.1.4. Rest of Latin America
  • 14.4. Market Attractiveness Analysis
  • 14.5. Market Trends
  • 14.6. Key Market Participants - Intensity Mapping
  • 14.7. Drivers and Restraints - Impact Analysis
  • 14.8. Country Level Analysis & Forecast
    • 14.8.1. Mexico Mammalian Cell Banking Market Analysis
      • 14.8.1.1. Introduction
      • 14.8.1.2. Market Analysis and Forecast by Market Taxonomy
    • 14.8.2. Brazil Mammalian Cell Banking Market Analysis
      • 14.8.2.1. Introduction
      • 14.8.2.2. Market Analysis and Forecast by Market Taxonomy
    • 14.8.3. Argentina Mammalian Cell Banking Market Analysis
      • 14.8.3.1. Introduction
      • 14.8.3.2. Market Analysis and Forecast by Market Taxonomy

15. Europe Mammalian Cell Banking Market Outlook, 2019-2032

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2024
  • 15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2025-2032
    • 15.3.1. By Country
      • 15.3.1.1. Italy
      • 15.3.1.2. Germany
      • 15.3.1.3. U.K
      • 15.3.1.4. France
      • 15.3.1.5. Spain
      • 15.3.1.6. BENELUX
      • 15.3.1.7. Nordic Countries
      • 15.3.1.8. Russia
      • 15.3.1.9. Rest of Europe
  • 15.4. Market Attractiveness Analysis
  • 15.5. Market Trends
  • 15.6. Key Market Participants - Intensity Mapping
  • 15.7. Drivers and Restraints - Impact Analysis
  • 15.8. Country Level Analysis & Forecast
    • 15.8.1. Italy Mammalian Cell Banking Market Analysis
      • 15.8.1.1. Introduction
      • 15.8.1.2. Market Analysis and Forecast by Market Taxonomy
    • 15.8.2. Germany Mammalian Cell Banking Market Analysis
      • 15.8.2.1. Introduction
      • 15.8.2.2. Market Analysis and Forecast by Market Taxonomy
    • 15.8.3. U.K. Mammalian Cell Banking Market Analysis
      • 15.8.3.1. Introduction
      • 15.8.3.2. Market Analysis and Forecast by Market Taxonomy
    • 15.8.4. France Mammalian Cell Banking Market Analysis
      • 15.8.4.1. Introduction
      • 15.8.4.2. Market Analysis and Forecast by Market Taxonomy
    • 15.8.5. Spain Mammalian Cell Banking Market Analysis
      • 15.8.5.1. Introduction
      • 15.8.5.2. Market Analysis and Forecast by Market Taxonomy
    • 15.8.6. BENELUX Mammalian Cell Banking Market Analysis
      • 15.8.6.1. Introduction
      • 15.8.6.2. Market Analysis and Forecast by Market Taxonomy
    • 15.8.7. Nordic Countries Mammalian Cell Banking Market Analysis
      • 15.8.7.1. Introduction
      • 15.8.7.2. Market Analysis and Forecast by Market Taxonomy
    • 15.8.8. Russia Mammalian Cell Banking Market Analysis
      • 15.8.8.1. Introduction
      • 15.8.8.2. Market Analysis and Forecast by Market Taxonomy

16. South Asia Mammalian Cell Banking Market Outlook, 2019-2032

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2024
  • 16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2025-2032
    • 16.3.1. By Country
      • 16.3.1.1. India
      • 16.3.1.2. Indonesia
      • 16.3.1.3. Malaysia
      • 16.3.1.4. Thailand
      • 16.3.1.5. Rest of South Asia
    • 16.3.2. By Cell
  • 16.4. Market Attractiveness Analysis
  • 16.5. Market Trends
  • 16.6. Key Market Participants - Intensity Mapping
  • 16.7. Drivers and Restraints - Impact Analysis
  • 16.8. Country Level Analysis & Forecast
    • 16.8.1. India Mammalian Cell Banking Market Analysis
      • 16.8.1.1. Introduction
      • 16.8.1.2. Market Analysis and Forecast by Market Taxonomy
    • 16.8.2. Indonesia Mammalian Cell Banking Market Analysis
      • 16.8.2.1. Introduction
      • 16.8.2.2. Market Analysis and Forecast by Market Taxonomy
    • 16.8.3. Malaysia Mammalian Cell Banking Market Analysis
      • 16.8.3.1. Introduction
      • 16.8.3.2. Market Analysis and Forecast by Market Taxonomy
    • 16.8.4. Thailand Mammalian Cell Banking Market Analysis
      • 16.8.4.1. Introduction
      • 16.8.4.2. Market Analysis and Forecast by Market Taxonomy

17. East Asia Mammalian Cell Banking Market Outlook, 2019-2032

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2024
  • 17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2025-2032
    • 17.3.1. By Country
      • 17.3.1.1. China
      • 17.3.1.2. Japan
      • 17.3.1.3. South Korea
  • 17.4. Market Attractiveness Analysis
  • 17.5. Market Trends
  • 17.6. Key Market Participants - Intensity Mapping
  • 17.7. Drivers and Restraints - Impact Analysis
  • 17.8. Country Level Analysis & Forecast
    • 17.8.1. China Mammalian Cell Banking Market Analysis
      • 17.8.1.1. Introduction
      • 17.8.1.2. Market Analysis and Forecast by Market Taxonomy
    • 17.8.2. Japan Mammalian Cell Banking Market Analysis
      • 17.8.2.1. Introduction
      • 17.8.2.2. Market Analysis and Forecast by Market Taxonomy
    • 17.8.3. South Korea Mammalian Cell Banking Market Analysis
      • 17.8.3.1. Introduction
      • 17.8.3.2. Market Analysis and Forecast by Market Taxonomy

18. Oceania Mammalian Cell Banking Market 2019-2024 and Forecast 2025-2032

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2024
  • 18.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2025-2032
    • 18.3.1. By Country
      • 18.3.1.1. Australia
      • 18.3.1.2. New Zealand
  • 18.4. Market Attractiveness Analysis
  • 18.5. Market Trends
  • 18.6. Key Market Participants - Intensity Mapping
  • 18.7. Drivers and Restraints - Impact Analysis
  • 18.8. Country Level Analysis & Forecast
    • 18.8.1. Australia Mammalian Cell Banking Market Analysis
      • 18.8.1.1. Introduction
      • 18.8.1.2. Market Analysis and Forecast by Market Taxonomy
    • 18.8.2. New Zealand Mammalian Cell Banking Market Analysis
      • 18.8.2.1. Introduction
      • 18.8.2.2. Market Analysis and Forecast by Market Taxonomy

19. Middle East and Africa (MEA) Mammalian Cell Banking Market Outlook, 2019-2032

  • 19.1. Introduction
  • 19.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2024
  • 19.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2025-2032
    • 19.3.1. By Country
      • 19.3.1.1. GCC Countries
      • 19.3.1.2. Turkey
      • 19.3.1.3. South Africa
      • 19.3.1.4. North Africa
      • 19.3.1.5. Rest of Middle East and Africa
  • 19.4. Market Attractiveness Analysis
  • 19.5. Market Trends
  • 19.6. Key Market Participants - Intensity Mapping
  • 19.7. Drivers and Restraints - Impact Analysis
  • 19.8. Country Level Analysis & Forecast
    • 19.8.1. GCC Countries Mammalian Cell Banking Market Analysis
      • 19.8.1.1. Introduction
      • 19.8.1.2. Market Analysis and Forecast by Market Taxonomy
    • 19.8.2. Turkey Mammalian Cell Banking Market Analysis
    • 19.8.3. South Africa Mammalian Cell Banking Market Analysis
    • 19.8.4. North Africa Mammalian Cell Banking Market Analysis

20. Market Structure Analysis

  • 20.1. Market Analysis by Tier of Companies
  • 20.2. Market Share Analysis of Top Players (%)
  • 20.3. Market Presence Analysis
    • 20.3.1. By Regional Footprint of Players
    • 20.3.2. Cell Footprint of Players
    • 20.3.3. Channel Footprint of Players

21. Competition Analysis

  • 21.1. Competition Dashboard
  • 21.2. Competition Benchmarking
  • 21.3. Competition Deep Dive
    • 21.3.1. Eurofins DiscoverX Corporation
      • 21.3.1.1. Overview
      • 21.3.1.2. Product & Services Portfolio
      • 21.3.1.3. Key Financials
      • 21.3.1.4. SWOT Analysis
      • 21.3.1.5. Key Developments
      • 21.3.1.6. Sales Footprint
      • 21.3.1.7. Strategy Overview
        • 21.3.1.7.1. Marketing Strategy
        • 21.3.1.7.2. Product Strategy
        • 21.3.1.7.3. Channel Strategy
    • 21.3.2. Merck KGaA
    • 21.3.3. Sartorius Stedim BioOutsource Limited.
    • 21.3.4. Charles River Laboratories
    • 21.3.5. Altogen Labs
    • 21.3.6. Abzena Ltd
    • 21.3.7. Northway Biotechpharma
    • 21.3.8. Lonza Group Ltd
    • 21.3.9. VIRUSURE
    • 21.3.10. Selexis SA
    • 21.3.11. Sigma-Aldrich
    • 21.3.12. Takara Bio Inc

22. Assumptions and Acronyms Used

23. Research Methodology